E-CANE: a National Program of Remote Health Education Workshops
NCT ID: NCT06748820
Last Updated: 2024-12-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
48 participants
OBSERVATIONAL
2025-01-01
2028-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Remote Therapeutic Patient Education (e-TPE)
TPE is a set of practices aiming at allowing a patient to acquire and preserve abilities and skills to manage actively their disease, cares, and surveillance, in collaboration with the caregivers
Remote Therapeutic Patient Education (e-TPE)
TPE is a set of practices aiming at allowing a patient to acquire and preserve abilities and skills to manage actively their disease, cares, and surveillance, in collaboration with the caregivers
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Remote Therapeutic Patient Education (e-TPE)
TPE is a set of practices aiming at allowing a patient to acquire and preserve abilities and skills to manage actively their disease, cares, and surveillance, in collaboration with the caregivers
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient followed by an AYA Coordinating Nurse in one of the 27 French AYA centres.
* Patient with Life expectancy ≥ 6 months.
* Patient ealth status consistent with program requirements.
* Karnosky index \> 60%.
* Patient who agrees to participate in the program and benefits from social security.
* Patient able to understand, speak and read French.
* Patient with no major cognitive impairment (assessed by the patient's referees).
* Patient with no sensory disability.
* Patient with access to a computer tool (smartphone, tablet, computer) and a WiFi or 4G network.
* Non opposition from patient or their legal representative collected.
* Patient who has signed the Privacy Policy.
* Patient who consented to participate in PTE program.
Exclusion Criteria
* Known superior cognitive function disorders.
* Progressive psychiatric pathology
* Drug user or alcohol abuse
15 Years
25 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nice
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU NICE
Nice, Alpes Maritimes, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Maryline Poirée
Role: primary
Audrey Jullian
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
24OncoHémato01
Identifier Type: -
Identifier Source: org_study_id